Andrew von Eschenbach

News / Photos

2 of 13

FDA COMMISSIONER ANDREW VON ESCHENBACH

Acting Food and Drug Administration (FDA) Commissioner Andrew von Eschenbach testifies before a Senate Agriculture Subcommittee hearing on the FDA's FY2007 proposed budget, in Washington on March 14, 2006. (UPI Photo/Kevin Dietsch)

License photo

Enlarge

UPI Related News

FDA opens offices in China

WASHINGTON, Nov. 18 (UPI) -- The U.S. Food and Drug Administration opened three offices in China this week as part of an effort to improve the safety of food imported from the Asian nation.

FDA: Food protection plan shows progress

WASHINGTON, July 2 (UPI) -- The U.S. Food and Drug Administration says its plan to keep U.S. citizens enjoying one of the safest food supplies in the world shows significant progress.

Frank Tori named FDA chief scientist

WASHINGTON, April 9 (UPI) -- The U.S. Food and Drug Administration has appointed Dr. Frank Torti as its principal deputy commissioner and new chief scientist.

FDA names drug research chief

WASHINGTON, March 11 (UPI) -- The U.S. Food and Drug Administration has selected Dr. Janet Woodcock to become the agency's director of drug evaluation and research.

FDA creates pediatric review committee

WASHINGTON, Oct. 25 (UPI) -- The U.S. Food and Drug Administration announced the creation Thursday of an internal pediatric review committee.

Masoudi named FDA associate counsel

WASHINGTON, Oct. 16 (UPI) -- Gerald Masoudi has been named associate general counsel of the food and drug division of the U.S. Department of Health and Human Services.

U.S. FDA, Chinese officials meet in China

WASHINGTON, Oct. 15 (UPI) -- U.S. Food and Drug Administration Commissioner Dr. Andrew von Eschenbach has met with Chinese health officials to discuss the safety of imports.

FDA proposes new sunscreen rules

WASHINGTON, Aug. 23 (UPI) -- The U.S. Food and Drug Administration issued a proposal Thursday setting standards for formulating, testing and labeling over-the-counter sunscreen products.

FDA urged to address nanotechnology safety

WASHINGTON, July 25 (UPI) -- The U.S. Food and Drug Administration's Nanotechnology Task Force released a report Wednesday urging the agency consider addressing nanotechnology risks.

FDA requests diabetes drug warnings

WASHINGTON, June 7 (UPI) -- The U.S. Food and Drug Administration is requesting safety warnings for diabetes drugs Avandia and Actos after they came under congressional scrutiny.

1 of 3 Prev | Next